Skip to content

Presurgery Anxiolysis in Children Treated With Hydroxyzine Versus Non-pharmacological Intervention (Distractoria Technique Clown)

Double-blind Randomized Clinical Trial to Compare Presurgery Anxiolysis in Children Treated With Hydroxyzine Versus Non-pharmacological Intervention (Distractoria Technique Clown)

Status
Terminated
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03324828
Acronym
SONRISA
Enrollment
170
Registered
2017-10-30
Start date
2017-11-01
Completion date
2020-05-29
Last updated
2020-08-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety

Keywords

anxiety, surgery, clown

Brief summary

This study evaluate the change in preoperative anxiety, baseline (M1) and pre-induction anxiety levels (M3), as shown by children undergoing MAS determined by the m-YPAS scale in the different APO management groups.Patients will be allocated in one of this four groups: hydroxyzine+clown; hydroxyzine alone, clowns alone or nothing

Interventions

Hydroxyzine solution

OTHERClowns intervention

Clowns intervention

Sponsors

Hospital San Carlos, Madrid
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Masking description

Clowns: outcomes assesor Hidroxicine: participant, care provider, investigator and outcomes assessor

Eligibility

Sex/Gender
ALL
Age
2 Years to 16 Years
Healthy volunteers
No

Inclusion criteria

* Children between 2 and 16 years old * Patients with programmed major ambulatory surgery. * Assessment of anesthetic risk ASA I-II. * Informed consent signed by their legal authorized representatives. * No antihistaminic allergies. * Assent signed by children between 12 and 16 years old.

Exclusion criteria

* Patients with previous surgeries. * Anesthetic risk ASA more than II. * Patients with hypersensitivity to the active substance, to any of the excipients, to cetirizine, to other piperazine derivatives, to aminophylline or etilenamida * Patients with porphyria * Patients with known QT prolongation, either congenital or acquired * Patients with known risk factors for QT prolongation including a pre-existing cardiovascular disease, previous electrolyte imbalances, family history of sudden cardiac death, significant bradycardia and concomitant use of drugs with potential known to produce QT prolongation and / or induce Torsades de Pointes.

Design outcomes

Primary

MeasureTime frameDescription
m-YPASAnxiety in the operation room (average 60 minutes from the begining of the study)Yale Preoperative Anxiety Scale (mYPAS)

Secondary

MeasureTime frameDescription
Cortisol level (salive)when the patient arrives at operation room(average 45 minutes from the begining of the study)cortisol blood test
m-YPASAnxiety when the patient arrives at operation room (average 45 minutes from the begining of the study)Yale Preoperative Anxiety Scale (mYPAS)
Cortisol level (blood)Just before starting surgery (average 75 minutes from the begining of the study)cortisol blood test
Anesthesia inductionJust before starting surgery (average 75 minutes from the begining of the study)Anesthesia induction according to the checklist

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 19, 2026